内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

GLP-1受体激动剂临床应用专家指导意见

2018-05-30 中国内分泌相关专家小组（统称） 中国糖尿病杂志.2018,26(5):353-361.

GLP-1受体激动剂糖尿病艾塞那肽利拉鲁肽贝那鲁肽利司那肽艾塞那肽周制剂

目前，我国已上市的ＧＬＰ－１受体激动剂包括艾塞那肽、利拉鲁肽、贝那鲁肽、利司那肽和艾塞那肽周制剂。为使我国临床医生及时、全面了解该类药物的最新临床证据，并在临床实践中更好的发挥该类药物的作用，我国部分临床专家在系统回顾ＧＬＰ－１受体激动剂的临床证据和相关指南的基础上达成该类药物临床应用的共识并制定《ＧＬＰ－１受体激动剂临床应用专家指导意见》，对ＧＬＰ－１受体激动剂的临床应用及相关证据进行全面介绍。

中文标题：

GLP-1受体激动剂临床应用专家指导意见

发布机构：

中国内分泌相关专家小组（统称）

发布日期：

2018-05-30

简要介绍：

目前，我国已上市的ＧＬＰ－１受体激动剂包括艾塞那肽、利拉鲁肽、贝那鲁肽、利司那肽和艾塞那肽周制剂。为使我国临床医生及时、全面了解该类药物的最新临床证据，并在临床实践中更好的发挥该类药物的作用，我国部分临床专家在系统回顾ＧＬＰ－１受体激动剂的临床证据和相关指南的基础上达成该类药物临床应用的共识并制定《ＧＬＰ－１受体激动剂临床应用专家指导意见》，对ＧＬＰ－１受体激动剂的临床应用及相关证据进行全面介绍。 

拓展指南：与糖尿病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=GLP-1受体激动剂临床应用专家指导意见)] GetToolGuiderByIdResponse(projectId=1, id=ae5fd1c001610e80, title=GLP-1受体激动剂临床应用专家指导意见, enTitle=, guiderFrom=中国糖尿病杂志.2018,26(5):353-361., authorId=null, author=, summary=目前，我国已上市的ＧＬＰ－１受体激动剂包括艾塞那肽、利拉鲁肽、贝那鲁肽、利司那肽和艾塞那肽周制剂。为使我国临床医生及时、全面了解该类药物的最新临床证据，并在临床实践中更好的发挥该类药物的作用，我国部分临床专家在系统回顾ＧＬＰ－１受体激动剂的临床证据和相关指南的基础上达成该类药物临床应用的共识并制定《ＧＬＰ－１受体激动剂临床应用专家指导意见》，对ＧＬＰ－１受体激动剂的临床应用及相关证据进行全面介绍。, cover=, journalId=null, articlesId=null, associationId=666, associationName=中国内分泌相关专家小组（统称）, associationIntro=这是一个统称，其下指南和专家共识均由国内内分泌领域的专家制定。, copyright=0, guiderPublishedTime=Wed May 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>目前，我国已上市的ＧＬＰ－１受体激动剂包括艾塞那肽、利拉鲁肽、贝那鲁肽、利司那肽和艾塞那肽周制剂。为使我国临床医生及时、全面了解该类药物的最新临床证据，并在临床实践中更好的发挥该类药物的作用，我国部分临床专家在系统回顾ＧＬＰ－１受体激动剂的临床证据和相关指南的基础上达成该类药物临床应用的共识并制定《ＧＬＰ－１受体激动剂临床应用专家指导意见》，对ＧＬＰ－１受体激动剂的临床应用及相关证据进行全面介绍。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>糖尿病</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=61de01c001606236" title="2018 JBDS-IP指南：糖尿病住院患者的自我管理" target=_blank>2018 JBDS-IP指南：糖尿病住院患者的自我管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0ba401c001603883" title="糖尿病检验诊断报告模式专家共识" target=_blank>糖尿病检验诊断报告模式专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6f8a11c0016025f4" title="老年人糖尿病前期干预指南" target=_blank>老年人糖尿病前期干预指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=bb86e1c001601155" title="2018 营养和饮食学会循证实践指南：妊娠糖尿病" target=_blank>2018 营养和饮食学会循证实践指南：妊娠糖尿病</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c75bb1c001593e29" title="2018年AACE/ACE《2型糖尿病综合管理策略》更新与解读" target=_blank>2018年AACE/ACE《2型糖尿病综合管理策略》更新与解读</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85" target=_blank>有关糖尿病更多指南</a></ul>, tagList=[TagDto(tagId=9617, tagName=GLP-1受体激动剂), TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=1897, tagName=艾塞那肽), TagDto(tagId=790, tagName=利拉鲁肽), TagDto(tagId=62293, tagName=贝那鲁肽), TagDto(tagId=45885, tagName=利司那肽), TagDto(tagId=77107, tagName=艾塞那肽周制剂)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7959, appHits=439, showAppHits=0, pcHits=5244, showPcHits=3226, likes=223, shares=19, comments=9, approvalStatus=1, publishedTime=Sun Jul 01 23:58:15 CST 2018, publishedTimeString=2018-05-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 01 23:58:15 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:56:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=GLP-1受体激动剂临床应用专家指导意见)])
GLP-1受体激动剂临床应用专家指导意见
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=896267, encodeId=4dc989626e54, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdLmurnCfUJdjpwom9CYVyH1haWlnwu6WpGCPJ7m22Uf8zEDefxib9LpLVicM4Do5no2iaJGK83NiaLicVwvIzLwySYh/0, createdBy=44ab1669662, createdName=1de0abe1m65(暂无匿称), createdTime=Mon Nov 02 15:04:50 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808000, encodeId=117280800047, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:51 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807999, encodeId=9db880e9998e, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:48 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807998, encodeId=423180e99898, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:44 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807997, encodeId=c1bd80e997df, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:42 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-11-02 1de0abe1m65(暂无匿称)

    学习了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=896267, encodeId=4dc989626e54, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdLmurnCfUJdjpwom9CYVyH1haWlnwu6WpGCPJ7m22Uf8zEDefxib9LpLVicM4Do5no2iaJGK83NiaLicVwvIzLwySYh/0, createdBy=44ab1669662, createdName=1de0abe1m65(暂无匿称), createdTime=Mon Nov 02 15:04:50 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808000, encodeId=117280800047, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:51 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807999, encodeId=9db880e9998e, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:48 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807998, encodeId=423180e99898, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:44 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807997, encodeId=c1bd80e997df, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:42 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-08-12 14643f34m67暂无昵称

    学习好资料

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=896267, encodeId=4dc989626e54, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdLmurnCfUJdjpwom9CYVyH1haWlnwu6WpGCPJ7m22Uf8zEDefxib9LpLVicM4Do5no2iaJGK83NiaLicVwvIzLwySYh/0, createdBy=44ab1669662, createdName=1de0abe1m65(暂无匿称), createdTime=Mon Nov 02 15:04:50 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808000, encodeId=117280800047, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:51 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807999, encodeId=9db880e9998e, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:48 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807998, encodeId=423180e99898, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:44 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807997, encodeId=c1bd80e997df, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:42 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-08-12 14643f34m67暂无昵称

    学习好资料

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=896267, encodeId=4dc989626e54, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdLmurnCfUJdjpwom9CYVyH1haWlnwu6WpGCPJ7m22Uf8zEDefxib9LpLVicM4Do5no2iaJGK83NiaLicVwvIzLwySYh/0, createdBy=44ab1669662, createdName=1de0abe1m65(暂无匿称), createdTime=Mon Nov 02 15:04:50 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808000, encodeId=117280800047, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:51 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807999, encodeId=9db880e9998e, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:48 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807998, encodeId=423180e99898, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:44 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807997, encodeId=c1bd80e997df, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:42 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-08-12 14643f34m67暂无昵称

    学习好资料

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=896267, encodeId=4dc989626e54, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdLmurnCfUJdjpwom9CYVyH1haWlnwu6WpGCPJ7m22Uf8zEDefxib9LpLVicM4Do5no2iaJGK83NiaLicVwvIzLwySYh/0, createdBy=44ab1669662, createdName=1de0abe1m65(暂无匿称), createdTime=Mon Nov 02 15:04:50 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808000, encodeId=117280800047, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:51 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807999, encodeId=9db880e9998e, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:48 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807998, encodeId=423180e99898, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:44 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807997, encodeId=c1bd80e997df, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Wed Aug 12 11:29:42 CST 2020, time=2020-08-12, status=1, ipAttribution=)]
    2020-08-12 14643f34m67暂无昵称

    学习好资料

    0

相关指南

2016 南亚共识指南：斋月期间应用GLP-1受体激动剂

国外内分泌相关专家小组（统称） · 2016-06-01